Westminster Health Forum – Biosimilars in the NHS

Tuesday 16 July, 2019 starting at 08:30 - 13:00

1 Wimpole Street, London, UK

The Westminster Health Forum will hold their event on Biosimilars in the NHS – commissioning, development, and engagement with clinicians and patients. The organisers say:

“Delegates will consider the progress of biosimilar use in the NHS and the role of Regional Medicines Optimisation Committees in coordinating uptake. It follows NHS England’s commitment to reduce spending on medicines by £300m by 2021 through increased use of biosimilars, as outlined in the Commissioning framework for biological medicines.

“Following the inclusion of biosimilars in the new Voluntary Scheme for Branded Medicines Pricing and Access, attendees will also assess whether biosimilar prices are subject to market competition and the impact of payment mechanisms and price control on market access of new biosimilars.

“The seminar follows the announcement of the new Accelerated Access Collaborative (AAC), and delegates will consider what support can be provided by the AAC to pharmaceutical companies bringing new products to the market, including accelerating the regulatory process and clarifying the evidence required to evaluate cost-effectiveness.”

More information | Agenda | Registration

Tagged with

The Location

1 Wimpole Street, London, UK

Event Location is here:
1 Wimpole Street, London, UK

Published on 3. June 2019 in

Back to the Events Page